Molina Healthcare, INC. Stock: price and directors' dealings · United States · SEC (Form 4)Track the Molina Healthcare, INC. stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Molina Healthcare, INC. has published 286 reports. Market capitalisation: €11.6bn. The latest transaction was reported on 2 July 2026 (Attribution). Among the most active insiders: ORLANDO STEVEN J. Every trade is free.
Analyst consensus: bullish or bearish? Analysts rate Molina Healthcare, INC. Hold (neutral), based on 17 analysts. Average price target: US$210.76.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,521 of 29,064 companies
FCF yld -6.1%
Earn yld 4.5%
EV/EBITDA 36.7x
ROE -0.2%
Gross mgn 9.0%
Net mgn 1.0%
Debt/EBITDA 10.1x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 July 2026
All Executives286 Thresholds0 Prospectus0 Other0
Declarations 286 total
◆ Director · Executives · 1 Jul 2026
237 shares Common Stock SEC:0001169490-26-000006:0
◆ EVP, Medicaid · Executives · 30 Jun 2026
23 shares Common Stock SEC:0002010075-26-000006:0
● EVP, Medicaid · Executives · 1 Jul 2026
183 shares Common Stock SEC:0002010075-26-000006:1
◆ Chief Legal Officer · Executives · 30 Jun 2026
138 shares Common Stock SEC:0001555603-26-000006:0
▼ Chief Accounting Officer · Executives · 14 May 2026
600 shares @ US$191.55 0.0011% mcap 17.0% of flow Common Stock SEC:0001267043-26-000004:0
◆ Director · Executives · 1 Apr 2026
405 shares @ US$135.82 3.4% of flow Common Stock SEC:0001169490-26-000004:0
◆ Director · Executives · 1 Apr 2026
405 shares @ US$135.82 59.2% of flow Common Stock SEC:0001257996-26-000004:0
◆ Director · Executives · 1 Apr 2026
405 shares @ US$135.82 5.5% of flow Common Stock SEC:0001856013-26-000004:0
◆ Director · Executives · 1 Apr 2026
405 shares @ US$135.82 2.5% of flow Common Stock SEC:0001206684-26-000006:0
◆ Director · Executives · 1 Apr 2026
405 shares @ US$135.82 1.5% of flow Common Stock SEC:0001211493-26-000004:0
◆ Director · Executives · 1 Apr 2026
405 shares @ US$135.82 2.2% of flow Common Stock SEC:0001228861-26-000004:0
◆ Director · Executives · 1 Apr 2026
405 shares @ US$135.82 5.5% of flow Common Stock SEC:0001263714-26-000006:0
◆ Director · Executives · 1 Apr 2026
405 shares @ US$135.82 1.9% of flow Common Stock SEC:0001649773-26-000004:0
▼ Director · Executives · 12 Mar 2026
506 shares @ US$146.92 3.0% of flow Common Stock SEC:0001206684-26-000004:0
● EVP, Medicaid · Executives · 1 Mar 2026
716 shares @ US$154.05 3.1% of flow Common Stock SEC:0002010075-26-000004:0
● Chief Financial Officer · Executives · 1 Mar 2026
2,308 shares @ US$154.05 2.0% of flow Common Stock SEC:0001690677-26-000002:0
● Chief Legal Officer · Executives · 1 Mar 2026
1,638 shares @ US$154.05 1.1% of flow Common Stock SEC:0001555603-26-000002:0
● President & CEO · Executives · 1 Mar 2026
8,597 shares @ US$154.05 1.4% of flow Common Stock SEC:0001320929-26-000002:0
◆ Chief Accounting Officer · Executives · 1 Mar 2026
650 shares @ US$154.05 4.0% of flow Common Stock SEC:0001267043-26-000002:0
● Chief Operating Officer · Executives · 1 Mar 2026
1,313 shares @ US$154.05 1.0% of flow Common Stock SEC:0001213947-26-000002:0
▲ Director · Executives · 11 Feb 2026
800 shares @ US$125.16 7.8% of flow Common Stock SEC:0001263714-26-000004:0
Canonical exit: 12 May 2026 (T+90) ◆ EVP, Medicaid · Executives · 31 Dec 2025
22 shares @ US$147.51 0.1% of flow Common Stock SEC:0002010075-26-000002:0
◆ Director · Executives · 1 Jan 2026
317 shares @ US$173.54 4.7% of flow Common Stock SEC:0001856013-26-000002:0
◆ Director · Executives · 1 Jan 2026
317 shares @ US$173.54 1.7% of flow Common Stock SEC:0001649773-26-000002:0
◆ Director · Executives · 1 Jan 2026
317 shares @ US$173.54 4.3% of flow Common Stock SEC:0001263714-26-000002:0
25 of 286 declarations
Load more (261 remaining) 关于 Molina Healthcare, INC. Molina Healthcare, Inc. (NYSE: MOH) 是一家领先的美国管理式医疗公司,专注于政府资助的医疗保健项目和低收入人群。该公司成立于1980年,最初是一家为南加州低收入家庭提供服务的供应商组织,后于2002年在特拉华州重新注册。其总部位于美国加利福尼亚州长滩。对于投资者而言,Molina Healthcare 稳居美国上市医疗保健领域,其商业模式具有防御性,但对报销趋势、州合同和监管执行高度敏感。([sec.gov](https://www.sec.gov/Archives/edgar/data/1179929/000117992925000023/moh-20241231.htm?utm_source=openai))
Molina 的运营模式围绕三个主要业务线:医疗补助 (Medicaid)、医疗保险 (Medicare) 和市场 (Marketplace)。医疗补助仍然是核心引擎,公司根据与美国各州签订的长期合同,为州政府资助的受益人管理健康计划。其医疗保险业务面向老年人,包括双重符合资格的人群和其他管理式医疗细分市场,而市场业务则提供基于个人交易的保险。这种组合使 Molina 成为一个专业的公共项目管理式医疗平台,而非一个广泛的消费品牌;执行力、医疗成本控制和合同绩效是业绩的关键驱动因素。([sec.gov](https://www.sec.gov/Archives/edgar/data/1179929/000117992925000023/moh-20241231.htm?utm_source=openai))
从竞争角度来看,Molina 在医疗补助管理式医疗领域的深度使其与众不同,在这个市场中,州关系、定价纪律和运营一致性比品牌知名度更重要。公司通过赢得合同和有针对性的收购不断扩大其业务范围,这支持了保费收入增长并扩大了其地理规模。公司近期披露的信息强调了在多个州的新增和扩展业务,以及与收购相关的增长贡献。([investors.molinahealthcare.com](https://investors.molinahealthcare.com/news-releases/news-release-details/molina-healthcare-reports-second-quarter-2025-financial-results?utm_source=openai))
从地理上看,Molina 在美国多个州拥有广泛的业务足迹,历史根源在加利福尼亚州,并通过医疗补助、医疗保险和市场项目在其他州扩大了业务。最新业绩显示,公司在2025年仍处于增长模式,全年保费收入约为 $43.1 billion,2026年指引接近 $42 billion,这反映了收购、费率上涨和有机增长的综合影响。管理层还指出医疗成本压力上升,并宣布计划在2027年退出传统的 Medicare Advantage Part D 产品,这对中期投资者来说是一个重要的战略和利润考量。([investors.molinahealthcare.com](https://investors.molinahealthcare.com/news-releases/news-release-details/molina-healthcare-reports-fourth-quarter-and-year-end-2025?utm_source=openai))
总而言之,Molina Healthcare 是一家在纽约证券交易所上市、总部位于美国的高质量美国管理式医疗特许经营公司,拥有强大的医疗补助主导模式、严谨的运营概况以及基于公共项目合同的增长战略。近期发展表明其持续扩张,但也凸显了该行业面临报销周期、利用率压力和政策驱动变化的风险。([investors.molinahealthcare.com](https://investors.molinahealthcare.com/news-releases/news-release-details/molina-healthcare-reports-fourth-quarter-and-year-end-2025?utm_source=openai))